Raymond Townsend, Director at Kindred Biosciences, Inc. (KIN), bought 3,000 shares at $6.04 ($18K) on 2015-08-14, disclosed to the SEC on 2015-08-17.
Open-market purchase of $18k KIN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| KIN | SELL | 2018-03-14 | $860 | — | Filing → |
| KIN | SELL | 2018-01-04 | $121K | — | Filing → |
| KIN | BUY | 2015-11-24 | $8K | — | Filing → |